Write claims for the competitor and the courtroom
Draft against the design-around, claim so one actor infringes, and treat every amendment as a possible surrender.
Lesson 4 of 9 · 4 min

Your real reader is an opponent
An examiner reviews your claims to decide whether to allow them. A competitor reads them looking for a way out. WIPO tells drafters they "should always try to ensure that competitors, either actual or potential, cannot circumvent the claimed invention", and warns that rivals will read the file for "damaging admissions" (WIPO Patent Drafting Manual).
Selden's car patent is the cautionary tale. As one secondary account tells it, a court reportedly held his patent valid but not infringed by Ford's different engine (JD Supra). We have not read that opinion, but the point holds as a warning: a valid patent that a rival can step around does little.
A judge decides what your words mean
Deciding what claim words mean is called claim construction, and it belongs to the court (Markman). Subsidiary facts found along the way are reviewed for clear error (Teva v. Sandoz). The specification "is the single best guide to the meaning of a disputed term" (Phillips, quoted in MPEP § 2111). Your examples and definitions will be used to read your claims, whether or not you meant them that way.
Amendments have a price
The doctrine of equivalents can reach a substitute that falls outside a claim's literal words. It applies element by element (Warner-Jenkinson).
Festo adds the price. Narrowing a claim during examination "may be presumed to be a general disclaimer of the territory between the original claim and the amended claim". The presumption is rebuttable for unforeseeability, tangentiality or another reason (Festo). Graham made the same point in 1966 (Graham v. John Deere). Before you give ground to an examiner, ask what you are giving away.
Claim so that one actor infringes
Inducement means encouraging someone else to infringe, and there is no inducement without direct infringement (Limelight v. Akamai). One law firm summarizes the 2015 Akamai decision this way: an entity answers for others' steps only if it directs or controls them or they form a joint enterprise (Hunton). We have not read that opinion.
In our judgment, the safest habit is to write each method claim from one actor's point of view. If a user's phone does one step and a separate company's server does the next, you may have a claim that nobody infringes alone.
Timeless wisdom
Claims are tested by people trying to avoid them. Drafters "should always try to ensure that competitors, either actual or potential, cannot circumvent the claimed invention" (WIPO Patent Drafting Manual). The court decides what the words mean (Markman), and the specification is its best guide (Phillips, quoted in MPEP § 2111). Narrowing a claim can surrender the ground you gave up (Festo), and there is no inducement without direct infringement (Limelight v. Akamai).
What's current
As of November 6, 2026
Colibri v. Medtronic (July 18, 2025) extended prosecution history estoppel, the rule that what you give up during examination stays given up. Cancelling a claim during prosecution barred an equivalents theory on a retained claim that was never itself narrowed (opinion).
In Europe, G 1/25 (Sept. 3, 2026) limits description adaptation, so text left in the description may stay (G 1/25), and under G 1/24 the description "shall always be consulted" (G 1/24). In our judgment, treat definitions and embodiments as claim-construction material.
Key takeaways
- Draft against the design-around, not just the examiner.
- Your specification will be used to interpret your claims.
- Narrowing a claim during examination can give up ground for good.
- Write method claims so that one actor performs every step.
Check your understanding
Sources
- WIPO Patent Drafting Manual
- JD Supra, The Top Ten Patent Wars: Automobiles (secondary source)
- Markman v. Westview Instruments (U.S.)
- Teva v. Sandoz (U.S.)
- MPEP § 2111 (quoting Phillips)
- Warner-Jenkinson v. Hilton Davis (U.S.)
- Festo v. Shoketsu (U.S.)
- Graham v. John Deere (U.S.)
- Limelight v. Akamai (U.S.)
- Hunton, summary of Akamai v. Limelight (commentary)
- Colibri v. Medtronic (Fed. Cir. July 18, 2025)
- EPO Enlarged Board, G 1/25
- EPO Enlarged Board, G 1/24
The Academy is general education, not legal advice, and reading it doesn't create an attorney-client relationship. Patent law and fees change, so check the linked sources and have a registered patent attorney or agent review your situation before you file. Obsidyan sells patent software, including AI drafting tools, so weigh what these lessons say about AI tools with that in mind.
